Cargando…
Efficacy of probiotic Streptococcus thermophilus in counteracting TGF-β1-induced fibrotic response in normal human dermal fibroblasts
BACKGROUND: Abnormal and deregulated skin wound healing associated with prolonged inflammation may result in dermal fibrosis. Since the current therapeutic strategies revealed unsatisfactory, the investigation of alternative approaches such as those based on the use of specific probiotic strains cou...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764521/ https://www.ncbi.nlm.nih.gov/pubmed/36536411 http://dx.doi.org/10.1186/s12950-022-00324-9 |
_version_ | 1784853288829583360 |
---|---|
author | Lombardi, Francesca Augello, Francesca Rosaria Artone, Serena Bahiti, Blerina Sheldon, Jenna Marie Giuliani, Maurizio Cifone, Maria Grazia Palumbo, Paola Cinque, Benedetta |
author_facet | Lombardi, Francesca Augello, Francesca Rosaria Artone, Serena Bahiti, Blerina Sheldon, Jenna Marie Giuliani, Maurizio Cifone, Maria Grazia Palumbo, Paola Cinque, Benedetta |
author_sort | Lombardi, Francesca |
collection | PubMed |
description | BACKGROUND: Abnormal and deregulated skin wound healing associated with prolonged inflammation may result in dermal fibrosis. Since the current therapeutic strategies revealed unsatisfactory, the investigation of alternative approaches such as those based on the use of specific probiotic strains could provide promising therapeutic options. In this study, we aimed to evaluate whether the lysate from S. thermophilus could antagonize the fibrogenic effects of TGF-β1 in normal human dermal fibroblasts (NHDF). METHODS: NHDF were exposed to TGF-β1 to establish a fibrotic phenotype. Proliferation rate and cell number were measured using the IncuCyte® Live Cell Imager system and the trypan blue dye exclusion test. Phenoconversion markers (α-SMA and fibronectin) and collagen I levels were assessed by western blot and immunofluorescence. The mRNA levels of TGF-β1 were evaluated by RT-PCR. The Smad2/3 phosphorylation level as well as β-catenin and PPARγ expression, were assessed by western blot. The cell contractility function and migration of NHDF were studied using collagen gel retraction assay, and scratch wound healing assay, respectively. The effects of S. thermophilus lysate, alone or combined with TGF-β1, were evaluated on all of the above-listed parameters and markers associated with TGF-β1-induced fibrotic phenotype. RESULTS: Exposure to the S. thermophilus lysate significantly reduced the key mediators and events involved in the abnormal activation of myofibroblasts by TGF-β1 within the fibrotic profile. The S. thermophilus treatment significantly reduced cell proliferation, migration, and myo-differentiation. In addition, the treatment with probiotic lysate reduced the α-SMA, fibronectin, collagen-I expression levels, and affected the collagen contraction ability of activated dermal fibroblasts. Moreover, the probiotic targeted the TGF-β1 signaling, reducing Smad2/3 activation, TGF-β1 mRNA level, and β-catenin expression through the upregulation of PPARγ. CONCLUSION: This is the first report showing that S. thermophilus lysate had a remarkable anti-fibrotic effect in TGF-β1-activated NHDF by inhibiting Smad signaling. Notably, the probiotic was able to reduce β-catenin and increase PPARγ levels. The findings support our point that S. thermophilus may help prevent or treat hypertrophic scarring and keloids. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12950-022-00324-9. |
format | Online Article Text |
id | pubmed-9764521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97645212022-12-21 Efficacy of probiotic Streptococcus thermophilus in counteracting TGF-β1-induced fibrotic response in normal human dermal fibroblasts Lombardi, Francesca Augello, Francesca Rosaria Artone, Serena Bahiti, Blerina Sheldon, Jenna Marie Giuliani, Maurizio Cifone, Maria Grazia Palumbo, Paola Cinque, Benedetta J Inflamm (Lond) Research BACKGROUND: Abnormal and deregulated skin wound healing associated with prolonged inflammation may result in dermal fibrosis. Since the current therapeutic strategies revealed unsatisfactory, the investigation of alternative approaches such as those based on the use of specific probiotic strains could provide promising therapeutic options. In this study, we aimed to evaluate whether the lysate from S. thermophilus could antagonize the fibrogenic effects of TGF-β1 in normal human dermal fibroblasts (NHDF). METHODS: NHDF were exposed to TGF-β1 to establish a fibrotic phenotype. Proliferation rate and cell number were measured using the IncuCyte® Live Cell Imager system and the trypan blue dye exclusion test. Phenoconversion markers (α-SMA and fibronectin) and collagen I levels were assessed by western blot and immunofluorescence. The mRNA levels of TGF-β1 were evaluated by RT-PCR. The Smad2/3 phosphorylation level as well as β-catenin and PPARγ expression, were assessed by western blot. The cell contractility function and migration of NHDF were studied using collagen gel retraction assay, and scratch wound healing assay, respectively. The effects of S. thermophilus lysate, alone or combined with TGF-β1, were evaluated on all of the above-listed parameters and markers associated with TGF-β1-induced fibrotic phenotype. RESULTS: Exposure to the S. thermophilus lysate significantly reduced the key mediators and events involved in the abnormal activation of myofibroblasts by TGF-β1 within the fibrotic profile. The S. thermophilus treatment significantly reduced cell proliferation, migration, and myo-differentiation. In addition, the treatment with probiotic lysate reduced the α-SMA, fibronectin, collagen-I expression levels, and affected the collagen contraction ability of activated dermal fibroblasts. Moreover, the probiotic targeted the TGF-β1 signaling, reducing Smad2/3 activation, TGF-β1 mRNA level, and β-catenin expression through the upregulation of PPARγ. CONCLUSION: This is the first report showing that S. thermophilus lysate had a remarkable anti-fibrotic effect in TGF-β1-activated NHDF by inhibiting Smad signaling. Notably, the probiotic was able to reduce β-catenin and increase PPARγ levels. The findings support our point that S. thermophilus may help prevent or treat hypertrophic scarring and keloids. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12950-022-00324-9. BioMed Central 2022-12-19 /pmc/articles/PMC9764521/ /pubmed/36536411 http://dx.doi.org/10.1186/s12950-022-00324-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lombardi, Francesca Augello, Francesca Rosaria Artone, Serena Bahiti, Blerina Sheldon, Jenna Marie Giuliani, Maurizio Cifone, Maria Grazia Palumbo, Paola Cinque, Benedetta Efficacy of probiotic Streptococcus thermophilus in counteracting TGF-β1-induced fibrotic response in normal human dermal fibroblasts |
title | Efficacy of probiotic Streptococcus thermophilus in counteracting TGF-β1-induced fibrotic response in normal human dermal fibroblasts |
title_full | Efficacy of probiotic Streptococcus thermophilus in counteracting TGF-β1-induced fibrotic response in normal human dermal fibroblasts |
title_fullStr | Efficacy of probiotic Streptococcus thermophilus in counteracting TGF-β1-induced fibrotic response in normal human dermal fibroblasts |
title_full_unstemmed | Efficacy of probiotic Streptococcus thermophilus in counteracting TGF-β1-induced fibrotic response in normal human dermal fibroblasts |
title_short | Efficacy of probiotic Streptococcus thermophilus in counteracting TGF-β1-induced fibrotic response in normal human dermal fibroblasts |
title_sort | efficacy of probiotic streptococcus thermophilus in counteracting tgf-β1-induced fibrotic response in normal human dermal fibroblasts |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764521/ https://www.ncbi.nlm.nih.gov/pubmed/36536411 http://dx.doi.org/10.1186/s12950-022-00324-9 |
work_keys_str_mv | AT lombardifrancesca efficacyofprobioticstreptococcusthermophilusincounteractingtgfb1inducedfibroticresponseinnormalhumandermalfibroblasts AT augellofrancescarosaria efficacyofprobioticstreptococcusthermophilusincounteractingtgfb1inducedfibroticresponseinnormalhumandermalfibroblasts AT artoneserena efficacyofprobioticstreptococcusthermophilusincounteractingtgfb1inducedfibroticresponseinnormalhumandermalfibroblasts AT bahitiblerina efficacyofprobioticstreptococcusthermophilusincounteractingtgfb1inducedfibroticresponseinnormalhumandermalfibroblasts AT sheldonjennamarie efficacyofprobioticstreptococcusthermophilusincounteractingtgfb1inducedfibroticresponseinnormalhumandermalfibroblasts AT giulianimaurizio efficacyofprobioticstreptococcusthermophilusincounteractingtgfb1inducedfibroticresponseinnormalhumandermalfibroblasts AT cifonemariagrazia efficacyofprobioticstreptococcusthermophilusincounteractingtgfb1inducedfibroticresponseinnormalhumandermalfibroblasts AT palumbopaola efficacyofprobioticstreptococcusthermophilusincounteractingtgfb1inducedfibroticresponseinnormalhumandermalfibroblasts AT cinquebenedetta efficacyofprobioticstreptococcusthermophilusincounteractingtgfb1inducedfibroticresponseinnormalhumandermalfibroblasts |